May
Safety review of prostate cancer drugs
The US FDA will review prostate cancer treatment, Gonadotropin-Releasing Hormones agonists, following potential health risks
04 May 2010
Novel prostate cancer 'vaccine' approved
The US Food and Drug Administration has approved Dendreon's Provenge, a breakthrough development in the treatment of prostate cancer
04 May 2010
Galbraith settles with Cohn & Wolfe
Rebecca Galbraith has settled court proceedings issued by global public relations agency Cohn & Wolfe, where she used to be board director
04 May 2010
Sanofi-aventis and Glenmark partner
Sanofi-aventis and Glenmark Pharmaceuticals have entered into a licensing agreement for the development of chronic pain treatments
04 May 2010
International life sciences partnership
UK and US life sciences bodies agree to collaborate and promote closer interaction
05 May 2010
CCC Paris expands team
Chandler Chicco Companies, an inVentiv Health company, has announced the appointment of Isabelle Genin to its Paris office
05 May 2010
Sudler & Hennessey appoints CIO
Global healthcare communications organisation, Sudler & Hennessey, has appointed Wolfgang von Stuermer as chief information officer
05 May 2010
Regulatory Society links with Chinese
RAPS works with University of Shanghai to tailor regulatory education to Chinese regulatory professionals
05 May 2010
Merck acquires full control of ridaforolimus
Merck has restructured its agreement with ARIAD, acquiring full control of the development and commercialisation of ridaforolimus
06 May 2010
FDA approves Indian Sun's generic AD drug
The US FDA has approved Indian company Sun Pharma's generic equivalent of Forest Laboratory's Alzheimer's disease treatment Namenda
06 May 2010